Novo Nordisk (NYSE: NVO) has spent years building its reputation around treatments for diabetes and obesity, so investors have been watching its next generation drug...
Sharp
StubHub Holdings, Inc. (NYSE: STUB) opened the market today with shares down over 23% following a disappointing reaction from investors to its recent quarterly earnings...
